Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Cash (2021 - 2025)

Historic Change in Cash for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$3.8 million.

  • Biofrontera's Change in Cash fell 15378.49% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544000.0, marking a year-over-year increase of 19908.93%. This contributed to the annual value of $4.6 million for FY2024, which is 12875.51% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Change in Cash is -$3.8 million, which was down 15378.49% from $5.5 million recorded in Q2 2025.
  • Biofrontera's 5-year Change in Cash high stood at $22.8 million for Q4 2021, and its period low was -$10.4 million during Q4 2022.
  • In the last 5 years, Biofrontera's Change in Cash had a median value of -$1.6 million in 2021 and averaged -$245263.2.
  • The largest annual percentage gain for Biofrontera's Change in Cash in the last 5 years was 87046.26% (2025), contrasted with its biggest fall of 26653.19% (2025).
  • Quarter analysis of 5 years shows Biofrontera's Change in Cash stood at $22.8 million in 2021, then plummeted by 145.37% to -$10.4 million in 2022, then skyrocketed by 79.93% to -$2.1 million in 2023, then soared by 245.84% to $3.0 million in 2024, then plummeted by 226.06% to -$3.8 million in 2025.
  • Its Change in Cash stands at -$3.8 million for Q3 2025, versus $5.5 million for Q2 2025 and -$4.1 million for Q1 2025.